A groundbreaking study published in Progress in Neuropsychopharmacology & Biological Psychiatry reveals that cannabidiol (CBD) may effectively reduce fever and inflammation. Researchers at the University of São Paulo found that CBD lowered fever in mice by altering biological pathways related to stress and inflammation responses.

The study, led by Professor Luiz Guilherme S. Branco, demonstrated that CBD decreased levels of pro-inflammatory markers while increasing anti-inflammatory ones. Notably, CBD showed no impact on normal body temperature, suggesting it specifically targets inflammatory states.

This research opens new avenues for exploring CBD as a potential alternative to traditional fever-reducing medications, which often come with side effects. However, the team cautions that while promising, these findings are based on animal models and require further clinical trials to validate CBD’s efficacy and safety in humans.